Detalhe da pesquisa
1.
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
Nature
; 590(7847): 635-641, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429418
2.
Clinical Characteristics and Outcomes of Patients With COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant.
JAMA
; 327(7): 652-661, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085383
3.
Lung donation following SARS-CoV-2 infection.
Am J Transplant
; 21(12): 4073-4078, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332512
4.
Comparative Effectiveness of Surgical Approaches for Lung Cancer.
J Surg Res
; 263: 274-284, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309173
5.
Nonclassical Monocytes Promote Edema in Lung Allografts from Traumatic Brain Injury Donors.
Am J Respir Cell Mol Biol
; 64(3): 391-394, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33646091
6.
CD11b suppresses TLR activation of nonclassical monocytes to reduce primary graft dysfunction after lung transplantation.
J Clin Invest
; 132(14)2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838047
7.
Crosstalk between nonclassical monocytes and alveolar macrophages mediates transplant ischemia-reperfusion injury through classical monocyte recruitment.
JCI Insight
; 6(6)2021 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621212
8.
Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries.
Lancet Respir Med
; 9(5): 487-497, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811829
9.
Lung transplantation for patients with severe COVID-19.
Sci Transl Med
; 12(574)2020 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257409
10.
Lung transplantation for pulmonary fibrosis secondary to severe COVID-19.
medRxiv
; 2020 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140069
11.
Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages.
J Clin Invest
; 130(8): 4456-4469, 2020 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692317
12.
Genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors.
Mol Ther Oncolytics
; 3: 16026, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27933313